Last updated on July 2019

A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042 an Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors


Find a site near you

Start Over

Beth Zaharoff, Sr. Director, Patient ...

Spokane, WA United States
8.74miles
  Connect »